Human immunodeficiency virus 1 (HIV 1) protease inhibitors for the treatment of HIV infection a new class of antiretroviral drugs, can significantly reduce the mortality of HIV-infected patients, but in these patients the incidence of impaired glucose tolerance and diabetes rate increased significantly, the exact mechanism is unclear, there are experiments show that protease inhibitors can lead to peripheral insulin resistance [1], but its effect on islet β-cell function is not clear whether it will affect. In this study, rats were derived insulin-secreting cell line INS 1 cells as a model, was observed in vitro HIV 1 protease inhibitor Nelfinavir on pancreatic β cell function
HIV-1 protease inhibitor Nelfinavir reduces rat insulinoma INS-1 cells release insulin
ReplyDeleteHuman immunodeficiency virus 1 (HIV 1) protease inhibitors for the treatment of HIV infection a new class of antiretroviral drugs, can significantly reduce the mortality of HIV-infected patients, but in these patients the incidence of impaired glucose tolerance and diabetes rate increased significantly, the exact mechanism is unclear, there are experiments show that protease inhibitors can lead to peripheral insulin resistance [1], but its effect on islet β-cell function is not clear whether it will affect. In this study, rats were derived insulin-secreting cell line INS 1 cells as a model, was observed in vitro HIV 1 protease inhibitor Nelfinavir on pancreatic β cell function
Medchemexpress Can provide the above product,its website:www.medchemexpress.com
TAK-901
SB-743921
ARRY-520
Ispinesib
AMG 900
ROCK-II inhibitor
SGI-1776
Enzastaurin
Sotrastaurin
Chelerythrine Chloride